199 related articles for article (PubMed ID: 7784801)
1. The immunofluorescence evaluation of some subepidermal bullous diseases by use of NaCl-split skin.
Salavec M; Nozicka Z; Rozsívalová V; Pavlátová J
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1994; 37(2):67-71. PubMed ID: 7784801
[TBL] [Abstract][Full Text] [Related]
2. Repeat direct immunofluorescence to discriminate pemphigoid from epidermolysis bullosa acquisita.
Wuepper KD
Arch Dermatol; 1990 Oct; 126(10):1365. PubMed ID: 2221945
[No Abstract] [Full Text] [Related]
3. The use of skin substrates deficient in basement membrane molecules for the diagnosis of subepidermal autoimmune bullous disease.
Vodegel RM; Kiss M; Cjm De Jong M; Pas HH; Altmayer A; Molnar K; Husz S; Van Der Meer JB; Jonkman MF
Eur J Dermatol; 1998 Mar; 8(2):83-5. PubMed ID: 9649654
[TBL] [Abstract][Full Text] [Related]
4. 'Suction split' as a routine method to differentiate epidermolysis bullosa acquisita from bullous pemphigoid.
Feliciani C; Di Muzio M; Mohammad Pour S; Allegretti T; Amerio P; Toto P; Coscione G; Proietto G; Amerio P
J Eur Acad Dermatol Venereol; 1998 May; 10(3):243-7. PubMed ID: 9643329
[TBL] [Abstract][Full Text] [Related]
5. Epidermolysis bullosa acquisita and anti-p200 pemphigoid as major subepidermal autoimmune bullous diseases diagnosed by floor binding on indirect immunofluorescence microscopy using human salt-split skin.
Goyal N; Rao R; Shenoi SD; Pai S; Kumar P; Bhogal BS; Schmidt E; Zillikens D
Indian J Dermatol Venereol Leprol; 2017; 83(5):550-555. PubMed ID: 28749386
[TBL] [Abstract][Full Text] [Related]
6. Use of animal skin substrates for indirect immunofluorescence diagnosis of subepidermal autoimmune bullous diseases.
Kanitakis J; Cozzani E; Peyron E; Bourchany D; Claudy A
Arch Dermatol; 1994 Dec; 130(12):1558. PubMed ID: 7986134
[No Abstract] [Full Text] [Related]
7. Accuracy of indirect immunofluorescence on sodium chloride-split skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita.
Yang B; Wang C; Chen S; Chen X; Zhou G; Tian H; Yu M; Zhang D; Shi Z; Zhang F
Indian J Dermatol Venereol Leprol; 2011; 77(6):677-82. PubMed ID: 22016274
[TBL] [Abstract][Full Text] [Related]
8. Acquired epidermolysis bullosa with the clinical feature of Brunsting-Perry cicatricial bullous pemphigoid.
Kurzhals G; Stolz W; Meurer M; Kunze J; Braun-Falco O; Krieg T
Arch Dermatol; 1991 Mar; 127(3):391-5. PubMed ID: 1998371
[TBL] [Abstract][Full Text] [Related]
9. [Pemphigoid mimicking epidermolysis bullosa acquisita].
Delaporte E; Piette F; Janin A; Cozzani E; Joly P; Thomine E; Nicolas JF; Bergoend H
Ann Dermatol Venereol; 1995; 122(1-2):19-22. PubMed ID: 7668776
[TBL] [Abstract][Full Text] [Related]
10. Optimal conditions of 1 M NaCl splitting technique to demonstrate basement membrane zone antigens in bullous pemphigoid, epidermolysis bullosa acquisita and linear IgA bullous dermatoses.
Jenkins RE; Rodenas J; Bhogal BS; Black MM
Dermatology; 1994; 189 Suppl 1():133-4. PubMed ID: 8049556
[TBL] [Abstract][Full Text] [Related]
11. Floor-pattern salt-split skin cannot distinguish bullous pemphigoid from epidermolysis bullosa acquisita. Use of toad skin.
Pang BK; Lee YS; Ratnam KV
Arch Dermatol; 1993 Jun; 129(6):744-6. PubMed ID: 8507077
[TBL] [Abstract][Full Text] [Related]
12. Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping.
De Jong MC; Bruins S; Heeres K; Jonkman MF; Nieboer C; Boorsma DM; Pas HH; van der Meer JB
Arch Dermatol; 1996 Feb; 132(2):151-7. PubMed ID: 8629822
[TBL] [Abstract][Full Text] [Related]
13. A case of epidermolysis bullosa acquisita with autoantibody to anti-p200 pemphigoid antigen and exfoliative esophagitis.
Yamada T; Suzuki M; Koike Y; Kida K; Murata S; Ishii N; Hashimoto T; Ohtsuki M
Dermatology; 2006; 212(4):381-4. PubMed ID: 16707891
[TBL] [Abstract][Full Text] [Related]
14. 'Salt-split' test on normal, non-sun-exposed skin of patients with autoimmune subepidermal bullous diseases.
Pohla-Gubo G; Becher E; Romani N; Fritsch P; Hintner H
Dermatology; 1994; 189 Suppl 1():123. PubMed ID: 8049551
[No Abstract] [Full Text] [Related]
15. U-serrated immunodeposition pattern differentiates type VII collagen targeting bullous diseases from other subepidermal bullous autoimmune diseases.
Vodegel RM; Jonkman MF; Pas HH; de Jong MC
Br J Dermatol; 2004 Jul; 151(1):112-8. PubMed ID: 15270879
[TBL] [Abstract][Full Text] [Related]
16. Alterations of basement membrane zone in autoimmune subepidermal bullous diseases.
Woźniak K; Kowalewski C
J Dermatol Sci; 2005 Dec; 40(3):169-75. PubMed ID: 15990279
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
18. Studies on complement deposits in epidermolysis bullosa acquisita and bullous pemphigoid.
Mooney E; Falk RJ; Gammon WR
Arch Dermatol; 1992 Jan; 128(1):58-60. PubMed ID: 1371212
[TBL] [Abstract][Full Text] [Related]
19. A practical technique for differentiation of subepidermal bullous diseases: localization of in vivo-bound IgG by laser scanning confocal microscopy.
Wozniak K; Kazama T; Kowalewski C
Arch Dermatol; 2003 Aug; 139(8):1007-11. PubMed ID: 12925388
[TBL] [Abstract][Full Text] [Related]
20. Acquired bullous diseases of childhood: re-evaluation of diagnosis by indirect immunofluorescence examination on 1 M NaCl split skin and immunoblotting.
Kirtschig G; Wojnarowska F; Marsden RA; Edwards S; Bhogal B; Black MM
Br J Dermatol; 1994 May; 130(5):610-6. PubMed ID: 8204469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]